Myriad Genetics | MYGN - Equity Capital And Reserves


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Myriad Genetics

Myriad Genetics reported $835.2M in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.


Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US USD -38725000 16.46M
Agilent A:US USD 5.78B 172M
Becton, Dickinson and Co. BDX:US USD 25.69B 219M
Bruker BRKR:US USD 1.2B 85M
Danaher DHR:US USD 51.48B 1.4B
Exact Sciences EXAS:US USD 3.06B 14.55M
Hologic HOLX:US USD 5.3B 208.3M
Illumina ILMN:US USD 6.69B 94M
J&J JNJ:US USD 70.87B 5.94B
Mettler Toledo International MTD:US USD -24469000 49.26M
Myriad Genetics MYGN:US USD 835.2M 50.6M
NanoString Technologies NSTG:US USD 13.62M 32.19M
OraSure Technologies OSUR:US USD 394.18M 30.56M
Pacific Biosciences Of California PACB:US USD 692.12M 129.21M
Quest Diagnostics DGX:US USD 6.05B 157M
Quidel QDEL:US USD 5B 61.9M
Repligen RGEN:US USD 1.94B 29.79M
Thermo Fisher Scientific TMO:US USD 42.31B 1.72B
Veracyte VCYT:US USD 1.08B 6.06M
Waters WAT:US USD 599.82M 95.34M